PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7819598-0	1994	Exogenous CoQ10 preserves plasma ubiquinone levels in patients treated with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.	coenzyme Q10	10-15	3-hydroxy-3-methylglutaryl-CoA reductase	Homo sapiens	76-123	
18787645-5	2008	Statin, 3-hydroxy-3- methyl-glutaryl (HMG)-CoA reductase inhibitor therapy inhibits conversion of HMG-CoA to mevalonate and lowers plasma CoQ(10) concentrations.	coenzyme Q10	138-141	3-hydroxy-3-methylglutaryl-CoA reductase	Homo sapiens	8-56	
16048353-3	2005	HMG-CoA reductase is also the first committed rate-limiting step for the synthesis of a range of other compounds including steroid hormones and ubidecarenone (ubiquinone), otherwise known as coenzyme Q(10) (CoQ(10)).	coenzyme Q10	144-157	3-hydroxy-3-methylglutaryl-CoA reductase	Homo sapiens	0-17	
33482334-2	2021	CoQ10 biosynthesis decreases with age in different tissues including skin and its biosynthesis can be modulated by 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors such as statins.	coenzyme Q10	0-5	3-hydroxy-3-methylglutaryl-CoA reductase	Homo sapiens	155-173